Among these genes, STMN2 and MIF have been recently studied in the context of AD, whereas, MAPK4, STMN2, and TUBA4A were implicated in AD nearly two decades before but failed to establish as robust biomarker candidates. This evidence concerns the gene MIF and Alzheimer disease.